Call for Papers  

Article Details

Review Article

LncRNAs and MiRNAs: New Targets for Resveratrol in Ovarian Cancer Research

[ Vol. 30 , Issue. 28 ]


Shahla Chaichian*, Sepideh Arbabi Bidgoli, Banafsheh Nikfar and Bahram Moazzami   Pages 3238 - 3248 ( 11 )


Ovarian cancer (OC) is the 3rd common gynecologic cancer. Numerous procedures are involved in the growth of OC, like migration, angiogenesis, proliferation, apoptosis, invasion, and metastasis. Therefore, a better knowledge of the molecular processes complicated in ovarian tumorigenesis can lead to better measures for the prevention and treatment of the disease and its diagnosis. Long non-coding RNAs (LncRNAs), a subclass of non-coding RNAs, are much more diverse than previously thought. It is suggested that these RNAs may play a role in controlling complex cellular signaling mechanisms via binding to proteins and influencing their function. Nevertheless, our acquaintance with the participation of LncRNAs in the pathogenesis of OC is still restricted. Especially, we do not yet recognize how to pharmacologically correct the epi-mutations. Resveratrol, a natural polyphenol mostly derived from grapes, has been evaluated in many studies to find its cancer therapeutic potential. In the current paper, we aimed to review the role of resveratrol as a potential natural product on lncRNAs as novel diagnostic and therapeutic targets in OC and represent new insights for further investigations.


Ovarian cancer, lncRNAs, epigenetic, gynecological cancers, resveratrol, angiogenesis.


Read Full-Text article